SAN DIEGO--(BUSINESS WIRE)--Ichor Medical Systems, whose advanced electroporation system is being used worldwide to increase the effectiveness of DNA drug and vaccine delivery, has been awarded a two-year contract valued at over $900,000 by the United States Department of Defense to assist the United States Army Medical Research Institute of Infectious Diseases (USAMRIID) in Fort Detrick, Maryland, in the development of a DNA vaccine for equine encephalitis. The current contract extends Ichor’s long-standing relationship with USAMRIID that has generated promising results for electroporation-based delivery of a number of biodefense DNA vaccine candidates.
